NZD/USD drops sharply to near 0.6160 despite diminishing Fed small rate cut bets weighing on the US Dollar. Slower-than-expected US annual PPI boosted Fed 50 bps rate cut prospects. The RBNZ is ...

The consensus price target hints at a 27.8% upside potential for BeiGene (BGNE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...

Part of the COOLBat project team at partner Compos-itence in Leonberg Achieving climate-friendly production of enclosures for battery systems in electric vehicles and thereby shrinking the vehicles’ ...

INO-6160 is under clinical development by Inovio Pharmaceuticals and currently in Phase I for Human Immunodeficiency Virus (HIV) Infections (AIDS). According to GlobalData, Phase I drugs for Human ...

MRT-6160, a potent and highly selective VAV1-directed molecular glue degrader, represents a potential novel therapeutic approach for systemic and neurological autoimmune and inflammatory diseases ...